Topcon Medical Systems, Inc.
27
0
0
22
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
18.5%
5 terminated/withdrawn out of 27 trials
81.5%
-5.0% vs industry average
11%
3 trials in Phase 3/4
27%
6 of 22 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (27)
Comparison of Two OCT Device RNFL and GCIPL Measurements in Mild, Moderate, and Severe Glaucoma
Role: collaborator
Safety Study of the VEGA UV-A System to Treat Keratoconus
Role: lead
TopQ Cut-off Score Validation Study for 3D OCT-1 Maestro
Role: lead
Safety Study of the VEGA UV-A System to Treat Ectasia
Role: lead
Safety and Effectiveness Study of the VEGA UV-A System for Cross-linking in Eyes With Keratoconus and Ectasia
Role: lead
Topcon 3D OCT-1000 Optical Coherence Tomography System
Role: lead
Clinical Study of the Optic Disc Parameters
Role: lead
Clinical Validation of New OCT System
Role: lead
Slit Lamp and Digital Camera Attachment
Role: lead
Maestro Agreement and Precision Study II
Role: lead
Comparative Study of the Topcon Tonometers CT-800 and TRK-2P and the Haag-Streit Goldmann Manual Tonometer and Topcon SP-1P
Role: lead
Second Comparative Study of Specular Microscopes for Endothelial and Corneal Cell Measurements
Role: lead
TopQ Cutoff Threshold Validation Study for DRI OCT Triton Plus
Role: lead
Topcon 3D OCT-1 Maestro Reference Database Study II
Role: lead
Triton Fundus Autofluorescence and Fluorescein Angiography
Role: lead
Triton Agreement and Precision Study
Role: lead
Retinal Fundus Camera Evaluation
Role: lead
OCT Reference Database
Role: lead
Comparative Study of Non-contact Tonometers for Intraocular Pressure and Corneal Cell Thickness Measurements
Role: lead
Slit Lamp Model SL-D-301 and DC-4 Digital Camera Attachment
Role: lead